UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000011072
Receipt No. R000012954
Official scientific title of the study Histamine-2 Receptor Antagonist Versus Proton-Pump Inhibitor for the Prevention of Ulcer Bleeding Associated With Low-dose Aspirin in Patients With Very High Ulcer Risk (ASP (PPI_H2RA) Study)
Date of disclosure of the study information 2013/06/29
Last modified on 2017/05/11 (Ver. 7)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study

Histamine-2 Receptor Antagonist Versus Proton-Pump Inhibitor for the Prevention of Ulcer Bleeding Associated With Low-dose Aspirin in Patients With Very High Ulcer Risk (ASP (PPI_H2RA) Study)
Title of the study (Brief title)

H2RA VS PPI for the Prevention of Ulcer Bleeding Associated With Low-dose Aspirin in Patients With Very High Ulcer Risk
Region
Japan Asia(except Japan)

Condition
Condition Ulcer Bleeding Associated With Low-dose Aspirin in Patients With Very High Ulcer Risk
Classification by specialty
Medicine in general Gastroenterology Cardiology
Neurosurgery Cardiovascular surgery
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 to test the hypothesis that PPI is superior to H2RA for the prevention of recurrent ulcer bleeding in ASA users with a history ulcer bleeding.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Reccurent ulcer bleeding
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit
Blinding Double blind -all involved are blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Medicine
Interventions/Control_1 famotidine 40 mg/day
Interventions/Control_2 rabeprazole 20 mg/day
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1. A history of documented peptic ulcer bleeding (self-reported history without confirmation by the clinician is not acceptable)
2. Negative tests for H. pylori or successful eradication of H. pylori based on urease test and histology
3. Expected regular use of ASA for the duration of the trial
4. Age &#8805; 18
5. Written informed consent obtained
Key exclusion criteria 1. A history of gastric or duodenal surgery other than patch repair
2. Severe erosive esophagitis (LA grade C or D)
3. Gastric outlet obstruction
4. Terminal illness
5. Active malignancies
Target sample size 332

Research contact person
Name of lead principal investigator Francis KL Chan
Organization Chinese University of Hong Kong
Division name Faculty of Medicine
Address Prince of Wales Hospital, Shatin, N.T., Hong Kong
TEL 0666453811
Email

Public contact
Name of contact person Tetsuya Tanigawa
Organization Osaka City University Graduate School of Medicine
Division name Department of Gastroenterology
Address
TEL
Homepage URL
Email ttanigawa@med.osaka-cu.ac.jp

Sponsor
Institute Department of Gastroenterology
Osaka City University Graduate School of Medicine
Institute
Department

Funding Source
Organization self funding
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs YES
Study ID_1 NCT01408186
Org. issuing International ID_1 ClinicalTrials.gov
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 大阪市立大学 消化器内科
香港大学 消化器内科
佐賀大学 内科学
大阪医科大学 第二内科
島根大学  第二内科 木下芳一
大阪市立総合医療センター 消化器内科

Other administrative information
Date of disclosure of the study information
2013 Year 06 Month 29 Day

Progress
Recruitment status Completed
Date of protocol fixation
2011 Year 10 Month 30 Day
Anticipated trial start date
2012 Year 01 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Published
URL releasing results
Results
Other related information

Management information
Registered date
2013 Year 06 Month 29 Day
Last modified on
2017 Year 05 Month 11 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012954